Picture of Organon & Co logo

OGN Organon & Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Momentum

Relative Strength (%)
1m-6.75%
3m+16.6%
6m-19.31%
1yr-37.03%
Volume Change (%)
10d/3m-33.09%
Price vs... (%)
52w High-28.28%
50d MA+2.61%
200d MA+1.79%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)4.07
PEG Ratio (f)1.17
EPS Growth (f)3.6%
Dividend Yield (f)6.28%
Valuation (ttm)IndustryMarket
Price to Book Valuen/a
Price to Tang. Bookn/a
Price to Free Cashflow8.42
Price to Sales0.73
EV to EBITDA8.53

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.36%
Return on Equityn/a
Operating Margin10.75%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m7,7776,5326,3046,1746,2636,400.786,518.67-8.52%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+50.24-31.71-38.2-24.25-1.94+3.41+4.23n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Organon & Co EPS forecast chart

Profile Summary

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. The Company operates six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    March 11th, 2021
    Public Since
    May 14th, 2021
    No. of Shareholders
    69,973
    No. of Employees
    10,000
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconNew York Stock Exchange
    Shares in Issue
    255,638,256

    OGN Share Price Performance

    Upcoming Events for OGN

    Q1 2024 Organon & Co Earnings Release

    Organon & Co Annual Shareholders Meeting

    Q2 2024 Organon & Co Earnings Release

    Similar to OGN

    Picture of Abbvie logo

    Abbvie

    us flag iconNew York Stock Exchange

    Picture of Bausch Health Companies logo

    Bausch Health Companies

    us flag iconNew York Stock Exchange

    Picture of Bristol-Myers Squibb Co logo

    Bristol-Myers Squibb Co

    us flag iconNew York Stock Exchange

    Picture of Bristol-Myers Squibb Co logo

    Bristol-Myers Squibb Co

    us flag iconNew York Stock Exchange

    Picture of Cardinal Health logo

    Cardinal Health

    us flag iconNew York Stock Exchange

    FAQ